Navigation Links
Data Published at ASCO Find Correlation Between ChemoFx(R) Assay and Significantly Improved Overall Survival in Patients With Ovarian Cancer
Date:5/20/2008

Analysis Reveals Overall Survival Could be Extended if Patients Receive the

Most Effective Treatment Identified by ChemoFx

CHICAGO, May 20 /PRNewswire/ -- Precision Therapeutics Inc. announced today that the ChemoFx(R) Assay, a cell-based test that examines the response of a specific patient's tumor to various chemotherapies, correlates with significantly longer overall survival (OS) in patients with primary ovarian cancer. Patients who received a treatment determined by ChemoFx to lead to the best tumor response had an overall survival 1.4 times longer than those receiving a treatment shown by ChemoFx to be non-responsive.

Despite the fact that all patients had the same type of tumor, 88 percent of patients exhibited varying degrees of response to different agents when evaluated by the cell-based test. The analysis also found that nearly two-thirds of patients' tumors were more responsive to a treatment identified by ChemoFx, than to the treatment they actually received. Based on these results, a mathematical model was created to estimate survival had patients been treated with a drug that ChemoFx identified as more likely to result in a greater tumor response. The analysis found that median OS could be extended as much as 23 to 38 months.

"These overall survival data demonstrate that the responsiveness to treatment established by this sensitivity assay in the laboratory setting, may in fact translate into meaningful clinical outcomes for patients," said Thomas J. Herzog, MD, director of gynecologic oncology at the Columbia University Medical Center and lead investigator of the study. "If these results are confirmed in current ongoing trials, this will be a significant step towards establishing individualized treatment strategies for patients who will require chemotherapy."

About the Study

Patients analyzed in the study had stage II-IV primary epithelial ovarian cancer that was tested by ChemoFx between 1997 an
'/>"/>

SOURCE Precision Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
2. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
3. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
5. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
6. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
7. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. Tumor Eradication Article Published by Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 21, 2015  Leadership speaker and business author Mary Kelly, Ph.D ., is helping members ... Photo - http://photos.prnewswire.com/prnh/20150420/199849 ... ... ... possible to run a successful medical practice without pulling your hair out of your head or ...
(Date:4/21/2015)... 21, 2015  The increase of diabetes due ... for self-monitoring blood glucose (SMBG) meters and strips ... potential for this market.  Availability of inexpensive generic ... profit margins. Photo - http://photos.prnewswire.com/prnh/20150417/199443 ... & Sullivan, US Self-monitoring Blood Glucose Market ...
(Date:4/21/2015)... April 21, 2015  GenVec, Inc. (NASDAQ: ... a research collaboration agreement with the Laboratory of ... Institute of Allergy and Infectious Diseases, National Institutes ... will utilize GenVec,s proprietary gorilla adenovirus vectors to ... the LMIV in order to create and test ...
Breaking Medicine Technology:Medical Group Managers Build Effective Practices with Strategies from Leadership Expert Mary Kelly 2Medical Group Managers Build Effective Practices with Strategies from Leadership Expert Mary Kelly 3Medical Group Managers Build Effective Practices with Strategies from Leadership Expert Mary Kelly 4Medical Group Managers Build Effective Practices with Strategies from Leadership Expert Mary Kelly 5Noninvasive Glucose Monitors Creates Convergence with the Digital Health Era 2Noninvasive Glucose Monitors Creates Convergence with the Digital Health Era 3Noninvasive Glucose Monitors Creates Convergence with the Digital Health Era 4GenVec Announces Collaboration with the Laboratory of Malaria Immunology & Vaccinology 2GenVec Announces Collaboration with the Laboratory of Malaria Immunology & Vaccinology 3
... acute coronary syndrome being managed with percutaneous coronary ... ... Feb. 21 Daiichi,Sankyo Company, Limited (TSE: 4568) and Eli Lilly ... and Drug Administration (FDA) accepted,and designated Priority Review for the New ...
... Rx, a drug delivery,company specializing in dissolving thin ... completed a pilot clinical study for its,thin film ... in the prevention and treatment of nausea and ... ondansetron was studied against,GlaxoSmithKline,s Zofran ODT(R) product. Based ...
Cached Medicine Technology:FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel 2FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel 3MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study 2MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study 3
(Date:4/21/2015)... Zane Benefits, the leader in individual ... publication of a new guide “Health Reimbursement Accounts in ... the health insurance industry, including how employers can use ... what is permitted when implementing an HRA. This simple, ... which HRAs are compliant this year. , According ...
(Date:4/21/2015)... 2015 Autocarsinsurancetips.com has released a new ... auto insurance plans by comparing quotes. , ... the best policies in their neighborhood. The insurance market ... best offer simply by comparing different plans. , ... car insurance quotes. Insurance brokerage websites like http://autocarsinsurancetips.com/ ...
(Date:4/21/2015)... has released a new blog post explaining the importance of ... on a uto insurance prices . , Drivers ... for advantageous auto insurance discounts. Clients can now review multiple ... will also help them get the best rates in their ... cost coverage is no longer difficult as there are multiple ...
(Date:4/21/2015)... LifeWings Partners LLC today announced a toolkit to ... safety programs by getting more support from their physicians. ... ways to get more physician support and engagement in ... Act, the new model of health care reimbursement is ... volume of services. Health care leaders feel an increased ...
(Date:4/21/2015)... April 21, 2015 When a bandage ... can result. In order to solve this problem two ... Bandaging. , This improved bandage helps a cut, burn, ... pain and enhances air exposure. The bandage is easy ... The original design was submitted to the St. Louis ...
Breaking Medicine News(10 mins):Health News:Online Auto Insurance Quotes Can Help Clients Save Money 2Health News:Auto Insurance Quotes Offer Excellent Security for A Car 2Health News:LifeWings Announces New Physician Engagement Toolkit to Help Hospitals Weather Serious Ramifications of the Affordable Care Act 2
... Legislation passed today by the Democratically-controlled Michigan House ... the pockets of personal injury lawyers at the ... of Commerce."By repealing Michigan,s lawsuit abuse protections, the ... Michigan becomes a lawsuit magnet," said Wendy Block, ...
... real-time communication tools like instant messenger, texts and mobile ... engage with physicians."A lot of people at our company ... sales executive in a roundtable discussion conducted by Best ... distracted by doing four things at once that the ...
... or chasing a cat causes many tumbles, CDC reports, , , ... be favored companions of many Americans, but they,re also apparently ... each year. , U.S. health officials report that 86,629 people ... people a day who wind up in hospital emergency rooms, ...
... Bill Puts Patient Health and Safety and ... The Generic Pharmaceutical Association (GPhA) released ... and CEO Kathleen Jaeger regarding the bipartisan ... Access to Life-Saving Medicine Act.""Momentum is skyrocketing ...
... used bacteria to strip the drink of carbs , , ... say they,ve developed a low-calorie, low-sugar vegetable juice for ... said it uses lactic acid-producing bacteria (LAB) to remove ... other nutrients. LAB, also known as probiotics, are used ...
... Three researchers at the Johns Hopkins University School of Medicine ... Medical Institute (HHMI). Xinzhong Dong, Ph.D., Joshua Mendell, M.D., Ph.D., ... but also become employees of HHMI, which will provide research ... "We are thrilled for Xinzhong, Josh and Sin for being ...
Cached Medicine News:Health News:Sales Force Effectiveness: Less Texting, More Engagement 2Health News:For All Their Plusses, Pets Pose a Risk for Falls, Too 2Health News:For All Their Plusses, Pets Pose a Risk for Falls, Too 3Health News:GPhA Statement on the Introduction of the Bipartisan Senate Biogenerics Consensus Bill: 'Promoting Innovation and Access to Life-Saving Medicine Act' 2Health News:Three Johns Hopkins researchers named Howard Hughes Medical Institute early career scientists 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: